Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-11-15
pubmed:abstractText
It is unclear why some adolescents experience substantial bone mineral density (BMD) loss, while others experience a minimal decrease during depot medroxyprogesterone acetate (DMPA) use. We examined biopsychosocial factors in adolescents who experienced ?5% BMD loss from baseline compared with adolescents who experienced <5% BMD loss during DMPA use.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1879-0518
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-12
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
pubmed:affiliation
Division of Adolescent Medicine/Hasbro Children's Hospital and Department of Pediatrics/Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. zharel@lifespan.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study